^比較UC-II® 組別及葡萄糖胺+軟骨素組別的 LFI指數, UC-II® 組別的紓緩日常關節痛效能為葡萄糖胺及軟骨素組別的3倍 Crowley, D. C., Lau, F. C., Sharma, P. et al. (2009). International journal of medical sciences, 6(6), 312..
#動物測試結果 Song, J., Li, J., Yang, F. et al. (2019). Cell Death Dis 10, 336.|+Schön, C., Knaub, K., Alt, W. et al. (2022). Journal of integrative and complementary medicine, 28(6), 540-548.|1 Huang, Y., Dou, Y., Yang, B. et al. (2023). Cell stress & chaperones, 28(4), 385–394.|*動物測試結果 Shi, Y., et al. (2024). Theranostics, 14(15), 5999.|**Huang, H. (2022). Frontiers in Aging, 3. (每日服300毫克 NMN)|UC-II® is a trademark of Lonza|